Comment on "The End of Phase 3 Clinical Trials in Biosimilars Development?"

被引：8
|
作者：
Webster, Christopher J. [1 ]
Woollett, Gillian R. [2 ]
机构：
[1] BioApprovals, Acton, MA USA
[2] Avalere Hlth Inc, FDA Strategy & Regulatory Policy, Washington, DC 20036 USA
来源：
BIODRUGS | 2018年 / 32卷 / 05期
关键词：
D O I：
10.1007/s40259-018-0297-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：519 / 521
页数：3
相关论文
共 50 条
  • [41] Clinical Profile of Suvorexant in Phase3 Trials
    Herring, W. Joseph
    JOURNAL OF SLEEP RESEARCH, 2018, 27
  • [42] Updating Reports of Phase 3 Clinical Trials for Cancer
    Elimova, Elena
    Moignard, Stephanie
    Li, Xuan
    Yu, Manshu
    Xu, Wei
    Seruga, Bostjan
    Tannock, Ian F.
    JAMA ONCOLOGY, 2021, 7 (04) : 593 - 596
  • [43] Analysis of Genitourinary Rhabdomyosarcoma in Phase 3 clinical trials
    Campbell, Timothy
    Hunt, Trevor C.
    Li, Ashley
    Cheng, Zijing
    Malshy, Kamil
    Doersch, Karen
    Bandari, Jathin
    WORLD JOURNAL OF UROLOGY, 2024, 43 (01)
  • [44] Phase 0 Clinical Trials: An Answer to Drug Development Stagnation?
    LoRusso, Patricia M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) : 2586 - 2588
  • [45] Biosimilars clinical development program: Confirmatory clinical trials: A virtual/simulated case study comparing equivalence and non-inferiority approaches
    Fletcher, Mark P.
    BIOLOGICALS, 2011, 39 (05) : 270 - 277
  • [46] Randomized clinical trials in neurosurgery Comment
    Colli, Benedicto Oscar
    BRAZILIAN NEUROSURGERY-ARQUIVOS BRASILEIROS DE NEUROCIRURGIA, 2009, 28 (02): : 48 - 49
  • [47] Therapy and clinical trials - Editorial comment
    Ogunko, A
    Oboubie, K
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (06) : 671 - 673
  • [48] CLINICAL-TRIALS IN PSYCHIATRY - A COMMENT
    SHROUT, PE
    NEUROPSYCHOPHARMACOLOGY, 1992, 6 (01) : 49 - 50
  • [49] Therapy and clinical trials - Editorial comment
    Bachorik, FS
    CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (01) : 89 - 91
  • [50] Editorial comment - Therapy and clinical trials
    Chandalia, I
    Jialal, I
    CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (06) : 708 - 710
12345